Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus

This publication has 16 references indexed in Scilit:

• Parenteral Vaccination against Influenza Does Not Induce a Local Antigen‐Specific Immune Response in the Nasal Mucosa
  The Journal of Infectious Diseases, 2002
• A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants
  Vaccine, 2002
• Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti‐influenza vaccine*
  Journal of Medical Virology, 2001
• Safety, efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults
  Vaccine, 2001
• Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine.
  Pharmaceutical Research, 2001
• Studies of the 1996–1997 Inactivated Influenza Vaccine among Children Attending Day Care: Immunologic Response, Protection against Infection, and Clinical Effectiveness
  The Journal of Infectious Diseases, 2000
• Human immune responses to influenza virus vaccines administered by systemic or mucosal routes
  Vaccine, 1995
• Local and systemic influenza haemagglutinin-specific antibody responses following aerosol and subcutaneous administration of inactivated split influenza vaccine
  Vaccine, 1992
• Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunit
  Vaccine, 1988
• Strain specificity of serum antibody to the haemagglutinin of influenza A (H3N2) viruses in children following immunization or natural infection
  Epidemiology and Infection, 1981